This is supported by previous reports, which showed that β-cryptoxanthin acts as an antagonist of peroxisome proliferation-activated receptor gamma (PPARγ) and may improve lipid metabolism and inhibit obesity via the inhibition of adipocyte hypertrophy [59,60]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.